Biblio Discovery — Demo Discovery Service

38 results for "Bilodeau, Marc"

Showing 1–20 · 0.92 seconds · RSS

  1. Journal Article Full text

    The golden age of hepatology

    Bilodeau, Marc

    Can Liver J · 2019 · English · PubMed Central

  2. Journal Article Full text

    Management of Anticoagulation for Portal Vein Thrombosis in Individuals with Cirrhosis: A Systematic Review

    Huard, Geneviève; Bilodeau, Marc

    Int J Hepatol · 2012 · English · PubMed Central

    Non-neoplastic portal vein thrombosis (PVT) is an increasingly recognized complication of liver cirrhosis. It is often diagnosed fortuitously and can be either partial or complete. The clinical significance of PVT is not obvious except in some situations such as when patients are on the waiting…

  3. Journal Article Full text

    New treatment strategies against hepatitis C viral infection

    Bilodeau, Marc; Lamarre, Daniel

    Can J Gastroenterol · 2006 · English · PubMed Central

    Treatment of hepatitis C virus infection is currently based on a combination of pegylated interferon and ribavirin. Because efficacy of this therapy remains suboptimal and side effects sometimes problematic, major efforts have been put forward by scientists and the pharmaceutical industry to…

  4. Journal Article Full text

    MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype

    Tambay, Vincent; Raymond, Valérie-Ann; Bilodeau, Marc

    Cancers (Basel) · 2021 · English · PubMed Central

    SIMPLE SUMMARY: In the last decade, metabolic reprogramming has emerged as a driving characteristic of cancer cells. The MYC oncogene, a transcription factor, has become of growing interest as a fundamental driver of differential cancer cell metabolism. Furthermore, the non-essential amino acid…

  5. Journal Article Full text

    Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family

    Beauséjour, Yannick; Alvarez, Fernando; Beaulieu, Martin et al.

    Can J Gastroenterol · 2011 · English · PubMed Central

    Benign recurrent intrahepatic cholestasis is a rare clinical entity that is caused by mutations in the canalicular transport genes. The present report describes two individuals from the same family whose symptoms were typical of the clinical characteristics of type 2 benign recurrent intrahepatic…

  6. Journal Article Full text

    Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage

    Moirand, Romain; Bilodeau, Marc; Brissette, Suzanne et al.

    Can J Gastroenterol · 2007 · English · PubMed Central

    BACKGROUND AND AIMS: In view of increasing therapeutic efficacy, the delivery of hepatitis C virus (HCV) antiviral treatment is expected to increase. Yet practical experience reveals a low rate of treatment, particularly among intravenous drug users. The aim of the present study was to examine the…

  7. Journal Article Full text

    Novel Immunotherapies for Autoimmune Hepatitis

    Cassim, Shamir; Bilodeau, Marc; Vincent, Catherine et al.

    Front Pediatr · 2017 · English · PubMed Central

    Autoimmune hepatitis (AIH) is a multifactorial autoimmune disease of unknown pathogenesis, characterized by a loss of immunological tolerance against liver autoantigens resulting in the progressive destruction of the hepatic parenchyma. Current treatments are based on non-specific immunosuppressive…

  8. Journal Article Full text

    Immune-Mediated Hepatitis During Immune Checkpoint Inhibitor cancer Immunotherapy: Lessons From Autoimmune Hepatitis and Liver Immunology

    Hercun, Julian; Vincent, Catherine; Bilodeau, Marc et al.

    Front Immunol · 2022 · English · PubMed Central

    Immune checkpoint inhibitors (ICI) are being increasingly used to successfully treat several types of cancer. However, due to their mode of action, these treatments are associated with several immune-related adverse events (irAEs), including immune-mediated autoimmune-like hepatitis in 5 to 10% of…

  9. Journal Article Full text

    Cystic fibrosis liver disease: A condition in need of structured transition and continuity of care

    Hercun, Julian; Alvarez, Fernando; Vincent, Catherine et al.

    Can Liver J · 2019 · English · PubMed Central

    Liver disease affects one-third of patients with cystic fibrosis (CF) and it is one of the major causes of morbidity and mortality in these patients. Historically considered a disease of childhood, its impact is now seen more often in adulthood. The heterogeneous pattern of CF liver disease and its…

  10. Journal Article Full text

    Protection against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes

    Lacoste, Benoit; Raymond, Valérie-Ann; Lapierre, Pascal et al.

    PLoS One · 2016 · English · PubMed Central

    Collagen produced during the process of liver fibrosis can induce a hepatocellular protective response through ERK1 signalling. However, the influence of T cells and associated cytokine production on this protection is unknown. In addition, athymic mice are frequently used in hepatocellular…

  11. Journal Article Full text

    From in vivo to in vitro: Major metabolic alterations take place in hepatocytes during and following isolation

    Cassim, Shamir; Raymond, Valérie-Ann; Lapierre, Pascal et al.

    PLoS One · 2017 · English · PubMed Central

    The liver plays a key role in maintaining physiological homeostasis and hepatocytes are largely responsible for this. The use of isolated primary hepatocytes has become an essential tool for the study of nutrient physiology, xenobiotic metabolism and several liver pathologies. Since hepatocytes are…

  12. Journal Article Full text

    Glutaminase Reprogramming in Hepatocellular Carcinoma: Implications for Diagnosis, Prognosis, and Potential as a Novel Therapeutic Target

    Tambay, Vincent; Raymond, Valérie-Ann; Turcotte, Simon et al.

    Int J Mol Sci · 2025 · English · PubMed Central

    Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer, with a poor prognosis due to late diagnosis, limited curative therapies, and underlying liver disease. Glutamine metabolism, a crucial pathway in cancer, remains poorly understood in HCC, which develops in an already…

  13. Journal Article Full text

    Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis

    Hercun, Julian; Willems, Philippe; Bilodeau, Marc et al.

    JPGN Rep · 2022 · English · PubMed Central

    Studies on pediatric patients with primary sclerosing cholangitis (PSC) have been limited by short follow-up and inconsistent classification of pediatric patients with autoimmune hepatitis-sclerosing cholangitis overlap (AIC). We conducted a retrospective study of patients diagnosed with AIC or PSC…

  14. Journal Article Full text

    Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma

    Cassim, Shamir; Raymond, Valérie-Ann; Lacoste, Benoit et al.

    Oncotarget · 2018 · English · PubMed Central

    HCC (Hepatocellular carcinoma) cells exhibit greater metabolic plasticity than normal hepatocytes since they must survive in a dynamic microenvironment where nutrients and oxygen are often scarce. Using a metabolomic approach combined with functional in vitro and in vivo assays, we aimed to…

  15. Journal Article Full text

    Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties

    Lacoste, Benoit; Raymond, Valérie-Ann; Cassim, Shamir et al.

    PLoS One · 2017 · English · PubMed Central

    There are limited numbers of models to study hepatocellular carcinoma (HCC) in vivo in immunocompetent hosts. In an effort to develop a cell line with improved tumorigenicity, we derived a new cell line from Hepa1-6 cells through an in vivo passage in C57BL/6 mice. The resulting Dt81Hepa1-6 cell…

  16. Journal Article Full text

    Reprogramming of Glutamine Amino Acid Transporters Expression and Prognostic Significance in Hepatocellular Carcinoma

    Tambay, Vincent; Raymond, Valérie-Ann; Voisin, Laure et al.

    Int J Mol Sci · 2024 · English · PubMed Central

    Hepatocellular carcinoma (HCC) is the most prevalent primary liver malignancy and is a major cause of cancer-related mortality in the world. This study aimed to characterize glutamine amino acid transporter expression profiles in HCC compared to those of normal liver cells. In vitro and in vivo…

  17. Journal Article Full text

    An update on the management of chronic hepatitis C: Consensus guidelines from the Canadian Association for the Study of the Liver

    Myers, Robert P; Ramji, Alnoor; Bilodeau, Marc et al.

    Can J Gastroenterol · 2012 · English · PubMed Central

    Chronic hepatitis C remains a significant medical and economic burden in Canada, affecting nearly 1% of the population. Since the last consensus conference on the management of chronic hepatitis C, major advances have warranted a review of recommended management approaches for these patients…

  18. Journal Article Full text

    Repression of Repulsive Guidance Molecule C during Inflammation Is Independent of Hfe and Involves Tumor Necrosis Factor-α

    Constante, Marco; Wang, Dongmei; Raymond, Valérie-Ann et al.

    Am J Pathol · 2007 · English · PubMed Central

    Genetic iron overload, or hemochromatosis, can be caused by mutations in HFE, hemojuvelin, and hepcidin genes. Hepcidin, a negative regulator of intestinal iron absorption, is found to be inappropriately low in both patients and in animal models, indicating that proper control of basal hepcidin…

  19. Journal Article Full text

    Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment

    Cassim, Shamir; Raymond, Valérie-Ann; Dehbidi-Assadzadeh, Layla et al.

    Cell Cycle · 2018 · English · PubMed Central

    Hepatocellular carcinoma (HCC) is a metabolically heterogeneous cancer and the use of glucose by HCC cells could impact their tumorigenicity. Dt81Hepa1-6 cells display enhanced tumorigenicity compared to parental Hepa1-6 cells. This increased tumorigenicity could be explained by a metabolic…

  20. Journal Article Full text

    Effects of intraoperative hemodynamic management on postoperative acute kidney injury in liver transplantation: An observational cohort study

    Carrier, François Martin; Sylvestre, Marie-Pierre; Massicotte, Luc et al.

    PLoS One · 2020 · English · PubMed Central

    BACKGROUND: Intraoperative restrictive fluid management strategies might improve postoperative outcomes in liver transplantation. Effects of vasopressors within any hemodynamic management strategy are unclear. METHODS: We conducted an observational cohort study on adult liver transplant recipients…